An Appraisal of Novel Biomarkers for Evaluating and Monitoring Neurologic Diseases: Editorial Introduction.
作者信息
Shefner Jeremy M, Sabbagh Marwan N
机构信息
Department of Neurology, Barrow Neurological Institute, Phoenix, AZ, USA.
出版信息
Neurotherapeutics. 2017 Jan;14(1):1-3. doi: 10.1007/s13311-016-0502-y.
Abstract
摘要
相似文献
1
An Appraisal of Novel Biomarkers for Evaluating and Monitoring Neurologic Diseases: Editorial Introduction.评估和监测神经疾病的新型生物标志物：编辑引言
Neurotherapeutics. 2017 Jan;14(1):1-3. doi: 10.1007/s13311-016-0502-y.
2
Commentary: The endovascular procedure-specific neurological examination scheme.评论：血管内手术特定的神经学检查方案。
J Endovasc Ther. 2011 Aug;18(4):538-9. doi: 10.1583/10-3352C.1.
3
[Neuromonitoring with S-100 protein in the intensive care unit].重症监护病房中S-100蛋白的神经监测
Anaesthesist. 2004 Oct;53(10):959-64. doi: 10.1007/s00101-004-0743-8.
4
[Neural monitoring in general intensive medicine--clinical trials and instrument procedures].[普通重症医学中的神经监测——临床试验与仪器操作]
Anasthesiol Intensivmed Notfallmed Schmerzther. 2006 Nov;41(11):704-14. doi: 10.1055/s-2006-958841.
5
Neurologic intensive care unit monitoring.神经重症监护病房监测
Crit Care Clin. 1985 Jul;1(2):223-39.
6
A method for identifying mechanisms of neurologic injury from cardiac surgery.一种识别心脏手术所致神经损伤机制的方法。
Heart Surg Forum. 2004;7(6):348-52. doi: 10.1532/HSF98.20041088.
7
Somatosensory evoked potentials in neurosurgery.神经外科中的体感诱发电位
Clin Neurosurg. 1988;34:187-238.
8
Perinatal biomarkers in prematurity: early identification of neurologic injury.早产中的围产期生物标志物：神经损伤的早期识别
Int J Dev Neurosci. 2014 Aug;36:25-31. doi: 10.1016/j.ijdevneu.2014.04.002. Epub 2014 Apr 24.
9
Serum interleukin-8 as a predictive marker for a comparative neurologic outcome analysis of patients resuscitated after cardiopulmonary arrest.血清白细胞介素-8作为心肺复苏后复苏患者比较神经学结局分析的预测标志物。
Crit Care Med. 2003 Sep;31(9):2415-6; author reply 2416-7. doi: 10.1097/01.CCM.0000087045.38907.C1.
10
[Use of computers in the intensive observation of neurosurgical patients].[计算机在神经外科患者强化观察中的应用]
Zh Vopr Neirokhir Im N N Burdenko. 1980 May-Jun(3):6-16.
本文引用的文献
1
Magnetoencephalography and New Imaging Modalities in Epilepsy.癫痫中的脑磁图和新成像模式
Neurotherapeutics. 2017 Jan;14(1):4-10. doi: 10.1007/s13311-016-0506-7.
2
Urate as a Marker of Risk and Progression of Neurodegenerative Disease.尿酸作为神经退行性疾病风险和进展的标志物。
Neurotherapeutics. 2017 Jan;14(1):148-153. doi: 10.1007/s13311-016-0497-4.
3
Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis.肌萎缩侧索硬化症的基于液体的生物标志物
Neurotherapeutics. 2017 Jan;14(1):119-134. doi: 10.1007/s13311-016-0503-x.
4
Axonal Excitability in Amyotrophic Lateral Sclerosis : Axonal Excitability in ALS.肌萎缩侧索硬化症中的轴突兴奋性：肌萎缩侧索硬化症中的轴突兴奋性。
Neurotherapeutics. 2017 Jan;14(1):78-90. doi: 10.1007/s13311-016-0492-9.
5
Tau Imaging in Alzheimer's Disease Diagnosis and Clinical Trials.阿尔茨海默病诊断与临床试验中的tau蛋白成像
Neurotherapeutics. 2017 Jan;14(1):62-68. doi: 10.1007/s13311-016-0490-y.
6
Transcranial Magnetic Stimulation for the Assessment of Neurodegenerative Disease.用于评估神经退行性疾病的经颅磁刺激
Neurotherapeutics. 2017 Jan;14(1):91-106. doi: 10.1007/s13311-016-0487-6.
7
Electrical Impedance Myography and Its Applications in Neuromuscular Disorders.电阻抗肌电图及其在神经肌肉疾病中的应用。
Neurotherapeutics. 2017 Jan;14(1):107-118. doi: 10.1007/s13311-016-0491-x.
8
The Spectrum of Functional Rating Scales in Neurology Clinical Trials.神经病学临床试验中功能评定量表的范围
Neurotherapeutics. 2017 Jan;14(1):161-175. doi: 10.1007/s13311-016-0488-5.
9
Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases.血液生物标志物作为炎症性神经系统疾病的结局指标
Neurotherapeutics. 2017 Jan;14(1):135-147. doi: 10.1007/s13311-016-0486-7.
10
Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis.肌萎缩侧索硬化症的神经影像学终点
Neurotherapeutics. 2017 Jan;14(1):11-23. doi: 10.1007/s13311-016-0484-9.
Zotero 插件